Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1312610-07-3

Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate is a chemical compound characterized by the molecular formula C11H9BrO4. It is a derivative of benzo[d][1,3]dioxole, a heterocyclic compound that features a benzene ring fused to a 1,3-dioxole ring. The incorporation of a bromine atom and a carboxylic ester group endows this compound with a high degree of reactivity and versatility, making it a valuable building block in the synthesis of more complex organic molecules. Its unique chemical structure positions it as a promising candidate in pharmaceutical research and the development of new drugs.

1312610-07-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1312610-07-3 Structure

  • Basic information

    1. Product Name: Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate
    2. Synonyms: Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate
    3. CAS NO:1312610-07-3
    4. Molecular Formula: C10H9BrO4
    5. Molecular Weight: 273.08006
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1312610-07-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 360.6±42.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.595±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate(CAS DataBase Reference)
    10. NIST Chemistry Reference: Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate(1312610-07-3)
    11. EPA Substance Registry System: Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate(1312610-07-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1312610-07-3(Hazardous Substances Data)

1312610-07-3 Usage

Uses

Used in Organic Synthesis:
Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate is utilized as a key intermediate in organic synthesis for the creation of a variety of complex organic molecules. Its reactivity and structural features facilitate the formation of new chemical bonds and the construction of diverse molecular frameworks.
Used in Pharmaceutical Research:
In the pharmaceutical industry, Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate is employed as a starting material or a building block for the development of new drugs and pharmaceutical compounds. Its unique chemical properties allow for the exploration of novel therapeutic agents with potential applications in various medical fields.
Used in Drug Development:
Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate is used as a precursor in the synthesis of pharmaceutically active compounds. Its presence in the molecular structure can influence the pharmacokinetics, pharmacodynamics, and overall efficacy of the resulting drug candidates, contributing to the advancement of innovative treatments for various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 1312610-07-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,6,1 and 0 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1312610-07:
(9*1)+(8*3)+(7*1)+(6*2)+(5*6)+(4*1)+(3*0)+(2*0)+(1*7)=93
93 % 10 = 3
So 1312610-07-3 is a valid CAS Registry Number.

1312610-07-3Relevant articles and documents

Crystalline methyl carbamate compound

-

Paragraph 0041; 0042;0043; 0044; 0045, (2018/11/03)

The invention relates to a crystalline methyl carbamate compound, namely a crystal form of N-[(2S)-1-[(2S)-2-{4-[7-(4-{2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutyryl]pyrrolidin-2-yl]-1H-imidazol-4-yl}phenyl)-2H-1,3-benzodioxan-4-yl]-1H-imidazol-2-yl}pyrrolidin-1-yl]-3-methyl-1-oxybutan-2-yl]methyl carbamate dihydrochloride, a pharmaceutical composition containing the crystal form, anda use of the crystal form in preparation of drugs in treatment of hepatitis C virus.

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

-

, (2011/07/06)

The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1312610-07-3